Daniele Vitale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Daniele Vitale has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Ospina Stella
The Kirby Institute, University of New South Wales
1 shared publication - Anthony Dominic Kelleher
The Kirby Institute, University of New South Wales, Sydney, Australia
1 shared publication - Anupriya Aggarwal
Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia
1 shared publication - Christina Fichter
The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
1 shared publication Daniel Christ
Affiliations School of Medicine, St Vincent’s Clinical School, The University of New South Wales, Sydney, New South Wales, Australia, Garvan Institute of Medical Research, Sydney, New South Wales, Australia
1 shared publicationDavid A. Brown
Affiliations Westmead Institute for Medical Research, Sydney, New South Wales, Australia, New South Wales Health Pathology, Sydney, Australia
1 shared publication
Latest Publications
- Open Access
Bile acids mediate liver-bone marrow crosstalk
The modern dietary exposome is calorie dense and poor in nutritional quality resulting in high prevalence of fatty liver disease and an increasing incidence of cardiometabolic disease and cancer. We investigated the impact of dietary composition on the interaction between the liver and haematopoietic systems in mice. Using xenograft and chemical-induced liver cancer models, we find that liver tumours per se have a minimal impact on haematopoietic stem and progenitor cell (HSPC) responses. In contrast, alterations in dietary composition have profound effects on the liver-bone marrow axis. Specifically, exposure to sucrose with or without dietary cholesterol has minimal impact on the HSPC response, while perturbations in bile acid biosynthesis synergises with excess dietary cholesterol to enhance HSPC responses. Pharmacological restoration of bile acid biosynthesis partially reversed these effects. We conclude that the crosstalk between liver and bone marrow, and subsequent HSPC responses is regulated by bile acid biosynthesis.
Open AccessBile acids mediate liver-bone marrow crosstalk
The modern dietary exposome is calorie dense and poor in nutritional quality resulting in high prevalence of fatty liver disease and an increasing incidence of cardiometabolic disease and cancer. We investigated the impact of dietary composition on the interaction between the liver and haematopoietic systems in mice. Using xenograft and chemical-induced liver cancer models, we find that liver tumours per se have a minimal impact on haematopoietic stem and progenitor cell (HSPC) responses. In contrast, alterations in dietary composition have profound effects on the liver-bone marrow axis. Specifically, exposure to sucrose with or without dietary cholesterol has minimal impact on the HSPC response, while perturbations in bile acid biosynthesis synergises with excess dietary cholesterol to enhance HSPC responses. Pharmacological restoration of bile acid biosynthesis partially reversed these effects. We conclude that the crosstalk between liver and bone marrow, and subsequent HSPC responses is regulated by bile acid biosynthesis.
- Open Access
- 6 July 2021
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 18 (7) , e1003656
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response and its evasion by emerging viral variants and variant of concern (VOC) are unknown, but critical to understand reinfection risk and breakthrough infection following vaccination. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants, inhibition of Spike-driven virus–cell fusion, and infectious SARS-CoV-2 neutralization were characterized in 807 serial samples from 233 reverse transcription polymerase chain reaction (RT-PCR)–confirmed Coronavirus Disease 2019 (COVID-19) individuals with detailed demographics and followed up to 7 months. A broad and sustained polyantigenic immunoreactivity against SARS-CoV-2 Spike, Membrane, and Nucleocapsid proteins, along with high viral neutralization, was associated with COVID-19 severity. A subgroup of “high responders” maintained high neutralizing responses over time, representing ideal convalescent plasma donors. Antibodies generated against SARS-CoV-2 during the first COVID-19 wave had reduced immunoreactivity and neutralization potency to emerging Spike variants and VOC. Accurate monitoring of SARS-CoV-2 antibody responses would be essential for selection of optimal responders and vaccine monitoring and design.
- 6 July 2021
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 18 (7) , e1003656
Open AccessSARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response and its evasion by emerging viral variants and variant of concern (VOC) are unknown, but critical to understand reinfection risk and breakthrough infection following vaccination. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants, inhibition of Spike-driven virus–cell fusion, and infectious SARS-CoV-2 neutralization were characterized in 807 serial samples from 233 reverse transcription polymerase chain reaction (RT-PCR)–confirmed Coronavirus Disease 2019 (COVID-19) individuals with detailed demographics and followed up to 7 months. A broad and sustained polyantigenic immunoreactivity against SARS-CoV-2 Spike, Membrane, and Nucleocapsid proteins, along with high viral neutralization, was associated with COVID-19 severity. A subgroup of “high responders” maintained high neutralizing responses over time, representing ideal convalescent plasma donors. Antibodies generated against SARS-CoV-2 during the first COVID-19 wave had reduced immunoreactivity and neutralization potency to emerging Spike variants and VOC. Accurate monitoring of SARS-CoV-2 antibody responses would be essential for selection of optimal responders and vaccine monitoring and design.